Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
Br J Clin Pharmacol
.
2011 Dec;72(6):905-8.
doi: 10.1111/j.1365-2125.2011.04037.x.
Authors
Jean-Louis Montastruc
1
,
Agnès Sommet
,
Haleh Bagheri
,
Maryse Lapeyre-Mestre
Affiliation
1
Laboratoire de Pharmacologie Médicale et Clinique de la Faculté de Médecine, UMR-INSERM U 1027 Equipe de Pharmacoépidémiologie, Université de Toulouse, France. montastruc@cict.fr
PMID:
21658092
PMCID:
PMC3244636
DOI:
10.1111/j.1365-2125.2011.04037.x
No abstract available
Publication types
Comment
MeSH terms
Adverse Drug Reaction Reporting Systems / statistics & numerical data*
Drug-Related Side Effects and Adverse Reactions*
Female
Humans
Male
Memory Disorders / chemically induced*